1药网上涨2.73%，报3.637美元/股，总市值3152.17万美元

Core Insights - 1药网 (YI) experienced a stock price increase of 2.73% on December 16, closing at $3.637 per share, with a total market capitalization of $31.52 million [1] - As of March 31, 2025, 1药网 reported total revenue of 3.529 billion RMB, reflecting a year-on-year growth of 0.02%, while the net profit attributable to shareholders decreased by 28.12% to -17.649 million RMB [1] Group 1 - 1药网 is a leading player in China's internet healthcare sector, founded in 2010 by Liu Junling, and aims to connect patients with pharmaceuticals and medical services through digital technology [2] - The company operates a supply chain service platform in collaboration with pharmaceutical companies, distributors, and insurance firms, empowering B-end pharmacies and doctors to better serve users through an S2B2C model [2] - 1药网 has restructured the pharmaceutical health industry's value chain using digital means, providing efficient matching of demand and supply, and offering comprehensive solutions for public healthcare needs [2] Group 2 - The company owns several platforms, including the B2C pharmaceutical platform "1药网," the internet hospital "1诊," and the B2B pharmaceutical platform "1药城," achieving integration across B-end and C-end, online and offline, and self-operated and platform models [2] - 1药网 successfully went public on NASDAQ in 2018 under the ticker symbol "YI," becoming the first Chinese internet healthcare company to list in the United States [2]